Resultados da pesquisa

The safety and tolerability of spironolactone in patients with mild to moderate chronic kidney disease Por Nicola C. Edwards, Richard P. Steeds, Colin D. Chue, Paul M. Stewart, Charles J. Ferro, Jonathan N. Townend

Obter o texto integral

Hormonal regulation of (Na+,K+)-ATPase biosynthesis in the toad bladder. Effect of aldosterone and 3,5,3'-triiodo-L-thyronine. Por K. Geering, M Girardet, Claude Bron, J P Kraehenbühl, Bernard C. Rossier

Obter o texto integral

Spironolactone prevents alterations associated with cardiac hypertrophy produced by isoproterenol in rats: involvement of serum‐ and glucocorticoid‐regulated kinase type 1 Por Beatriz Martín‐Fernández, Natalia de las Heras, María Miana, Sandra Ballesteros, María Valero‐Muñoz, Dalton Valentim Vassallo, Ana Paula Davel, Luciana Venturini Rossoni, Victoria Cachofeiro, Vicente Lahera

Obter o texto integral Obter o texto integral

Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing Por Jingjing Zhao, J Li, W. Li, Y Li, Hong Qu Shan, Yanling Gong, Baofeng Yang

Obter o texto integral

Early Spironolactone Treatment Attenuates Heart Failure Development by Improving Myocardial Function and Reducing Fibrosis in Spontaneously Hypertensive Rats Por M. D. M. Cezar, R. L. Damatto, Luana Urbano Pagan, A. R. R. Lima, Paula Felippe Martinez, Camila Bonomo, C. M. Rosa, Dijon Henrique Salomé de Campos, Antônio Carlos Cicogna, Mariana Janini Gomes, S. A. Oliveira, Daniella Audi Blotta, Marina Politi Okoshi, Katashi Okoshi

Obter o texto integral Obter o texto integral

The negative inotropic action of canrenone is mediated by L‐type calcium current blockade and reduced intracellular calcium transients Por Andréa Rodrigues da Costa, Laila Brito Torres, Emiliano Medei, Rafael A. Ricardo, Jerônimo Pereira de França, Soraya S. Smaili, José Nascimento, Maria E.M. Oshiro, José Wilson Magalhães Bassani, Alice T. Ferreira, Paulo José Ferreira Tucci

Obter o texto integral

Impact of worsening renal function related to medication in heart failure Por Hans‐Peter Brunner‐La Rocca, Christian Knackstedt, Luc W.M. Eurlings, Vinzent Rolny, Friedemann Krause, Matthias Pfisterer, Daniel Tobler, Peter Rickenbacher, Micha T. Maeder

Obter o texto integral Obter o texto integral

Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1 Por Larbi Amazit, Florian Le Billan, Peter Kolkhof, Khadija Lamribet, Say Viengchareun, Michel Fay, Junaid Khan, Alexander Hillisch, Marc Lombès, M.E. Rafestin-Oblin, Jérôme Fagart

Obter o texto integral

A new oral therapy for long QT syndrome Por Susan P. Etheridge, Steven J. Compton, Martin Tristani‐Firouzi, Jay W. Mason

Obter o texto integral

Clinical Use of Diuretics in Heart Failure, Cirrhosis, and Nephrotic Syndrome Por Ahmed Hassaan Qavi, Rida Kamal, Robert W. Schrier

Obter o texto integral Obter o texto integral

Eplerenone for hypertension Por Tina SC Tam, May Wu, Sarah Masson, Matthew P Tsang, Sarah Stabler, Angus Kinkade, Anthony Tung, Aaron M Tejani

Obter o texto integral

Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study‐Heart Failure (ARTS‐HF): a randomized study of finerenone vs. eplerenone in patients who have worse... Por Bertram Pitt, Stefan D. Anker, Michael Böhm, Mihai Gheorghiade, Lars Køber, Henry Krum, Aldo P. Maggioni, Piotr Ponikowski, Adriaan A. Voors, Faı̈ez Zannad, Christina Nowack, So‐Young Kim, Alexander Pieper, Nina Kimmeskamp‐Kirschbaum, Gerasimos Filippatos

Obter o texto integral

Incidence and Predictors of Hyperkalemia in Patients With Heart Failure Por Akshay S. Desai, Karl Swedberg, John J.V. McMurray, Christopher B. Granger, Salim Yusuf, James B. Young, Mark E. Dunlap, Scott D. Solomon, James W. Hainer, Bertil Olofsson, Eric L. Michelson, Marc A. Pfeffer

Obter o texto integral

Spironolactone reduces blood pressure and albuminuria of obese hypertensive patients with Metabolic Syndrome Por Danielle Guedes Andrade Ezequiel, Rogério Baumgratz de Paula, Júlio César Moraes Lovisi, Thaís Chehuen Bicalho, Sergio Franca de Souza Filho, Sarah de Paula Iennaco de Rezende, Mônica Barros Costa

Obter o texto integral

Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy Por Eric K. Chin, David R.P. Almeida, C. Nathaniel Roybal, Philip Niles, Karen M. Gehrs, Elliott H. Sohn, H. Culver Boldt, Stephen R. Russell, James C. Folk

Obter o texto integral Obter o texto integral

Fracture Risk in Men With Congestive Heart Failure Por Laura Carbone, Jessica D. Cross, Syed Hasan Raza, Andrew Bush, Robert J. Sepanski, Saurabh S. Dhawan, Bilal Khan, Malini Gupta, Khurram Ahmad, Rami N. Khouzam, Dwight A. Dishmon, Joseph P. Nesheiwat, Mohammad Hajjar, Waqas Chishti, Wael Nasser, Mehwish Khan, Catherine Womack, Tara Cho, Ashley R. Haskin, Karl T. Weber

Obter o texto integral

Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites Por Pere Ginès, Vicente Arroyo, Enrique Quintero, Ramón Planas, Felipe Bory, Juan J. Cabrera, Antoni Rimola, Josep Maria Viver, Jordi Camps, Wladimiro Jiménez, Ricardo Mastaï, Joan Gaya, Joan Rodés

Obter o texto integral

Refractory Hypertension: Definition, Prevalence, and Patient Characteristics Por Maria Czarina Acelajado, Roberto Pisoni, Tanja Dudenbostel, Louis J. Dell’Italia, Falynn Cartmill, Bin Zhang, Stacey S. Cofield, Suzanne Oparil, David A. Calhoun

Obter o texto integral Obter o texto integral

Factors associated with 30-day readmission of patients with heart failure from a Japanese administrative database Por Hiroki Aizawa, Shinobu Imai, Kiyohide Fushimi

Obter o texto integral Obter o texto integral

Mineralocorticoid receptors are present in skeletal muscle and represent a potential therapeutic target Por Jessica Chadwick, J. Spencer Hauck, Jeovanna Lowe, Jeremiah J. Shaw, Denis C. Guttridge, Celso E. Gómez-Sánchez, Elise P. Gómez-Sánchez, Jill A. Rafael‐Fortney

Obter o texto integral